Patients with an advanced form of lung cancer lived 56 per cent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy ...

Major new research study identifies potential new ways to treat the most common type of bowel cancer, affecting more than 39,000 people in the UK each year. The study, conducted by an international ...

Experts at The Institute of Cancer Research, London, have hailed findings from a major international trial showing that a personalised cancer vaccine can significantly reduce the risk of melanoma ...

The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

Nearly one third (29.2 per cent) of patients with advanced melanoma saw their tumours disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, ...

The division is focused on identifying both the genetic and environmental causes of breast cancer, so we can improve diagnosis, assess prognosis and likely response to treatment more accurately, and ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Results released at the ...

Findings from researchers at The Institute of Cancer Research, London, will help clinicians advise parents of twin children with acute lymphoblastic leukaemia (ALL), offering guidance on risk level ...

Scientists have uncovered that an important chemical ‘probe’ compound widely used to study cancer in the lab – and also a related compound that has entered clinical evaluation in cancer patients – do ...

Image: A scanning electron microscope image of a prostate cancer cell. Credit: Anne Weston, Francis Crick Institute. CC BY-NC 4.0. At The Institute of Cancer Research, London, we often refer to ...